UNSPSC 51314328: Carbetapentane/chlorpheniramine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE502. This VA Drug Class (RE502) classifies this compound as belonging to the group ANTIHISTAMINE/DECONGESTANT/ANTITUSSIVE.

UNSPSC 51314328 Carbetapentane/chlorpheniramine is a Commodity code that in practice captures state and local procurement of pharmaceuticals and pharmaceutical products, though recent solicitation activity under this code shows a wider range of health-related supplies including naloxone, drug deactivation systems, and generic multi-source pharmaceuticals and over-the-counter products. State and local governments buying under this code include county health departments, state health and human services agencies, and cooperative purchasing alliances serving multiple jurisdictions. The work solicited ranges from direct purchase of specific pharmaceutical products with fixed unit costs to complex manufacturer agreements requiring compliance with cGMP, DSCSA, and FDA standards, with vendors often required to maintain relationships with authorized wholesalers and detailed product cataloging by NDC code.

Recent activity spans Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building and fixed-fee pricing on a two-year term with one-year renewal option. The Texas Health and Human Services Commission posted RFI HHS0017013 (April 3, 2026) to gather vendor capabilities for a Therapeutic Pharmacy Initiative direct-to-manufacturer prescriptions program, requesting information on vendors' capacity for direct contracting outside traditional pharmacy benefit manager and group purchasing organization channels. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities including Oregon, requiring vendor compliance with authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, Morris & Dickson) and submission of detailed product information with awards effective July 1, 2026.